ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,136 | -69.9% | 10,835 | -71.5% | 0.00% | -66.7% |
| Q1 2023 | $965,835 | -39.2% | 38,025 | -2.9% | 0.00% | -50.0% |
| Q4 2022 | $1,588,127 | +694.1% | 39,155 | +801.8% | 0.01% | +500.0% |
| Q1 2022 | $200,000 | -89.6% | 4,342 | -82.6% | 0.00% | -87.5% |
| Q4 2020 | $1,916,000 | +75.8% | 24,971 | -1.4% | 0.01% | +100.0% |
| Q3 2020 | $1,090,000 | -83.4% | 25,319 | -83.4% | 0.00% | -87.9% |
| Q2 2020 | $6,583,000 | +297.8% | 152,418 | +165.0% | 0.03% | +200.0% |
| Q1 2020 | $1,655,000 | -87.4% | 57,514 | -72.3% | 0.01% | -74.4% |
| Q4 2019 | $13,171,000 | +293.0% | 207,649 | +74.6% | 0.04% | +258.3% |
| Q3 2019 | $3,351,000 | +524.0% | 118,924 | +487.2% | 0.01% | +500.0% |
| Q2 2019 | $537,000 | +66.8% | 20,254 | +20.7% | 0.00% | +100.0% |
| Q3 2018 | $322,000 | +107.7% | 16,785 | +47.5% | 0.00% | 0.0% |
| Q2 2018 | $155,000 | – | 11,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |